What to Expect at the Protein Design & Engineering in BioPharma Summit?
As biopharma organizations continue to expand their protein R&D capabilities, teams are evaluating an increasingly diverse range of in silico design tools, experimental platforms and optimization strategies. Yet understanding which approaches deliver meaningful scientific and organizational value remains a key challenge.
The inaugural Protein Design & Engineering in Biopharma Summit brings together senior leaders across protein engineering, computational biology, structural biology, biophysics and biologics R&D to share practical lessons from the front lines of therapeutic protein design. Through case-study-led presentations and peer discussion, attendees will benchmark emerging wet-, dry-lab and hybrid technologies, explore platform-building strategies and gain actionable insights from organizations advancing the next generation of biologic therapeutics.
What Sets This Meeting Apart?
Engineering the Next Generation of Bispecific & Multispecific Antibodies
Explore how leading protein engineering teams are overcoming the challenges of multispecific design, balancing affinity, specificity, developability and manufacturability to create increasingly sophisticated therapeutic formats. Learn how innovators are engineering novel architectures, optimizing chain pairing and controlling molecular geometry to unlock improved efficacy across complex disease settings.
Designing Better T-Cell Engagers
Discover how the field is advancing beyond first-generation T-cell engagers through improved target selection, tunable binding strategies and rational protein engineering. Gain practical insights into optimizing potency, safety and manufacturability while addressing key challenges including cytokine release, off-target activity and therapeutic window.
Reimagining Antibody Engineering
From next-generation antibody discovery through to lead optimization, hear how leading organizations are integrating computational design, structural biology and experimental validation to engineer molecules with enhanced affinity, specificity, stability and developability. Benchmark approaches for accelerating antibody optimization while improving downstream translational success.
Expanding the Protein Engineering Toolbox
Beyond traditional antibodies, explore the rapidly growing landscape of mini-proteins, enzymes, protein scaffolds, vaccines and novel biologic modalities. Learn how advances in in silico design, screening and characterization are enabling entirely new therapeutic mechanisms, unlocking previously inaccessible targets and expanding the boundaries of what engineered proteins can achieve.
Attending Companies Include